Merkel cell carcinoma (MCC) is an aggressive, cutaneous, neuroendocrine carcinoma and, in rare cases, occurs with Bowen's disease (BD). In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of tumor-infiltrating leukocytes in the lesional skin of MCC and invasive BD. Interestingly, immunohistochemical study revealed significant numbers of CD8+ cells and caspase 3-expressing cells in the same areas of invasive BD and MCC. Our present case suggests that MCC concurrent with invasive BD might have a good prognosis because of the substantial number of CD8+ cells in the tumor.
Merkel cell carcinoma (MCC) is an aggressive, cutaneous, neuroendocrine carcinoma and, in rare cases, occurs with Bowen's disease (BD). In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of tumor-infiltrating leukocytes in the lesional skin of MCC and invasive BD. Interestingly, immunohistochemical study revealed significant numbers of CD8+ cells and caspase 3-expressing cells in the same areas of invasive BD and MCC. Our present case suggests that MCC concurrent with invasive BD might have a good prognosis because of the substantial number of CD8+ cells in the tumor.
Merkel cell carcinoma (MCC) is an aggressive, cutaneous, neuroendocrine carcinoma that originates from either Merkel cells or from pluripotent stem cells in the basal layer of the epidermis [1, 2]. Recent reports suggested that the type of tumor-infiltrating leukocytes (TILs) could determine the prognosis and tumor-specific survival of MCC [3, 4, 5]. Bowen's disease (BD) is defined as carcinoma in situ; the tumor shows atypical pleomorphism, cell clumping, irregular mitosis and individual cell keratinization. BD progresses to invasive BD, with the cytological characteristics of BD [6]. In addition, as we previously reported, both invasive and non-invasive BD contain substantial numbers of TILs, including CD8+ cells, Foxp3+ regulatory T cells (Tregs) and CD163+ macrophages [7]. Although several cases of MCC concurrent with BD have already been reported [8, 9], there has been no English language report investigating TILs in MCC with BD. In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of TILs in the lesional skin of MCC and invasive BD.
Case Report
A 71-year-old Japanese male visited our outpatient clinic with a 6-month history of a rapidly growing red plaque on his back. On his initial visit, physical examination revealed a red, pigmented plaque, 90 × 80 mm, with a dome-shaped elastic-soft nodule (fig. 1a). The diameter of the nodule was approximately 20 mm. A skin biopsy from the edge of the plaque revealed atypical squamous cells containing large oval nuclei with occasional conspicuous nucleoli, with individual keratinization, mitotic figures and clumping cells. In addition, the biopsy specimen from the center of the nodule revealed dense infiltrating atypical squamous cells throughout the dermis (fig. 1c). We first diagnosed this patient as invasive BD and excised the tumor with a 5-mm margin. Unexpectedly the histological finding of the whole tumor revealed that the squamous cell-composed tumor was surrounded by another type of tumor composed of small round cells with scant cytoplasm and oval nuclei (fig. 1b, d). These small round cells were positive for AE1/AE3, cytokeratin 20, synaptophysin and CD56, and negative for 34βE12, cytokeratin 7, chromogranin A and TTF1. From the above findings, we diagnosed this tumor as MCC concomitant with invasive BD. We screened for a possible internal malignancy with positron emission tomography computed tomography and found no evidence of metastasis.
Fig. 1
a Red, pigmented plaque on the back, 90 × 80 mm, with a dome-shaped elastic-soft nodule. b The squamous cell-composed tumor was surrounded by another type of tumor. c Center of the tumor (squamous cell-composing tumor area): the atypical squamous cells contained large oval nuclei and occasionally conspicuous nucleoli, with individual keratinization, mitotic figures and clumping cells. d Peripheral areas of the tumor: small round cells with scant cytoplasm and oval nuclei. Original magnification: b ×50; c, d ×200.
As we and other reports suggested [3, 4, 7], both invasive BD and MCC contain substantial numbers of immunoreactive and immunosuppressive cells. Notably, a previous report even suggested that the number of tumor-infiltrating CD8+ cells determines the prognosis of MCC [3]. Therefore, we further employed immunohistochemical staining for CD8 (fig. 2a, b), caspase 3 (fig. 2c, d), Foxp3 (fig. 3a, b), CD163 (fig. 3c, d) and CD206 (fig. 3e, f) in the lesional areas of invasive BD and MCC. Substantial numbers of immunoreactive and immunosuppressive cells were detected at the edge of the tumor in invasive BD, whereas TILs were scattered at the center of the tumor in MCC. Both invasive BD and MCC contained caspase 3-expressing cells in the CD8-infiltrated areas, which suggested induction of an anti-tumor immune response in the tumor microenvironment by CD8+ cytotoxic T cells.
Fig. 2
CD8+ cells and caspase 3+ cells in the areas of invasive BD and MCC. Paraffin-embedded tissue samples were deparaffinized and stained with anti-CD8 antibody (a, b) and anti-caspase 3 antibody (c, d) for the areas of invasive BD (a, c) and MCC (b, d). The sections were developed with liquid permanent red. Original magnification: ×200.
Fig. 3
Foxp3+ Tregs, CD163+ macrophages and CD206+ cells in the areas of invasive BD and MCC. Paraffin-embedded tissue samples were deparaffinized and stained with anti-Foxp3 antibody (a, b), anti-CD163 antibody (c, d) and anti-CD206 antibody (e, f) for the areas of invasive BD (a, c, e) and MCC (b, d, f). The sections were developed with liquid permanent red. Original magnification: ×200.
Discussion
Previous reports suggested the importance of evaluating the tumor microenvironment in the lesional skin of MCC. Indeed, Paulson et al. [3] reported an association between the infiltration of intratumoral CD8+ lymphocytes and improved MCC-specific survival. More recently, Dowlatshahi et al. [4] reported that a subset of tumor-associated macrophages (TAMs) in MCC expressed PD-L1, which contributes to the exhaustion of CD8+ effector T cells in the tumor microenvironment. Indeed, Afanasiev et al. [10] reported that Merkel cell polyomavirus (MCPyV)-specific CD8 T cells were detected directly ex vivo from the blood samples of patients with MCPyV-positive MCC. Interestingly, MCPyV-specific CD8 T cells and MCC-infiltrating lymphocytes expressed higher levels of therapeutically targetable PD-1 [10]. Notably, MCPyV contributes to the carcinogenesis of MCC [11]. From an immunological point of view, recent reports also suggested that the expression of B7-H molecules, including PD-L1, on TAMs and tolerogenic dendritic cells is regulated by Tregs, and that the induction of Tregs is mediated by TAMs by B7-H-related signaling [12]. In aggregate, these reports suggested the significance of crosstalk between Tregs and TAMs in the lesional skin of MCC, and these immunosuppressive cells might contribute to the exhaustion of MCC-specific CD8+ T cells to maintain an immunosuppressive tumor microenvironment.Concerning BD, we previously reported that substantial numbers of CD8+ cells were detected adjacent to tumor cells, and that the expression of PD-L1 on tumor cells diminished in parallel with the progression of BD, which might recover the exhausted CD8+ effector T cells in the tumor microenvironment of invasive BD, like MCC [4, 7]. Notably, although several cases of MCC concurrent with BD have already been reported [8, 9], to our knowledge, there is no English language report suggesting a prognostic factor for this type of tumor. In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of TILs in the lesional skin of MCC and invasive BD. Interestingly, immunohistochemical study revealed that both invasive BD and MCC contained significant numbers of CD8+ cells in the tumor lesion. Although this area contained substantial number of Foxp3+ Tregs and CD163+ TAMs, caspase 3-expressing cells were scattered in the lesional skin of BD and MCC, which might suggest induction of an anti-tumor immune response in the tumor microenvironment of MCC and BD. Our present case suggests that MCC concurrent with invasive BD might have a good prognosis because of the substantial number of CD8+ cells in the tumor. Since we did not directly assess the suppressive functions of these infiltrating cells, further analysis of the mechanisms underlying this phenomenon could offer fundamental insights into the mechanisms of our case. To confirm this hypothesis, further studies will be necessary in the future.
Authors: Kelly G Paulson; Jayasri G Iyer; Andrew R Tegeder; Renee Thibodeau; Janell Schelter; Shinichi Koba; David Schrama; William T Simonson; Bianca D Lemos; David R Byrd; David M Koelle; Denise A Galloway; J Helen Leonard; Margaret M Madeleine; Zsolt B Argenyi; Mary L Disis; Juergen C Becker; Michele A Cleary; Paul Nghiem Journal: J Clin Oncol Date: 2011-03-21 Impact factor: 44.544
Authors: Maryam M Asgari; Monica M Sokil; E Margaret Warton; Jayasri Iyer; Kelly G Paulson; Paul Nghiem Journal: JAMA Dermatol Date: 2014-07 Impact factor: 10.282
Authors: Mitra Dowlatshahi; Victor Huang; Ahmed E Gehad; Ying Jiang; Adam Calarese; Jessica E Teague; Andrew A Dorosario; Jingwei Cheng; Paul Nghiem; Carl F Schanbacher; Manisha Thakuria; Chrysalyne D Schmults; Linda C Wang; Rachael A Clark Journal: J Invest Dermatol Date: 2013-02-18 Impact factor: 8.551